MD21C2 - The method of obtaining 22(R,S)-11b, 21-dihidroxi-16a, 17 butylidenbisoxipregn-1,4-dien-3,20 dion - Google Patents
The method of obtaining 22(R,S)-11b, 21-dihidroxi-16a, 17 butylidenbisoxipregn-1,4-dien-3,20 dionInfo
- Publication number
- MD21C2 MD21C2 MD94-0086A MD940086A MD21C2 MD 21 C2 MD21 C2 MD 21C2 MD 940086 A MD940086 A MD 940086A MD 21 C2 MD21 C2 MD 21C2
- Authority
- MD
- Moldova
- Prior art keywords
- dion
- dien
- butylidenbisoxipregn
- dihidroxi
- obtaining
- Prior art date
Links
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000008064 anhydrides Chemical class 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Steroid Compounds (AREA)
Abstract
The invention relates to the steroids particularly to obtaining 22(R,S)-11β, 21-dihidroxi-16a, 17 butylidenbisoxipregn-1,4-dien-3,20 dion which has a pharmacological action on organism. The goal of the invention is to obtain this product with a desired isomer ratio. The synthesis is made by reaction 11β, 16a, 17-trihydroxi-21 acetoxi-pregn-1,4-dien-3,20-dion 16,17-ether metilyc of cicloortobornic acid with n-butiraldehyde, the molar ratio is 1:2, in the tetrahydrofuran medium in the presence of anhydride acetic at room temperature, saponifing the obtained product in the presence of perchloric acid. In this case a product is obtained with the isomer ratio 22R:S 1:1 with purity up to 96%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD940086A MD21B1 (en) | 1988-02-29 | 1994-02-25 | Method for obtaining 22 (r, s) 11beta, 21-dihydroxy-16alpha, 17-butylidenbisoxypregn-1,4-diene-3,20 dione |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU884355323A SU1711675A3 (en) | 1988-02-26 | 1988-02-29 | Method of 22(r,s)-11@@@,21-dihydroxy-16@@@,17-butylidene-bis- oxypregna-1,4-d- iene-3,20-dione synthesis |
| MD940086A MD21B1 (en) | 1988-02-29 | 1994-02-25 | Method for obtaining 22 (r, s) 11beta, 21-dihydroxy-16alpha, 17-butylidenbisoxypregn-1,4-diene-3,20 dione |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD21C2 true MD21C2 (en) | 1994-05-31 |
| MD21B1 MD21B1 (en) | 1994-05-31 |
Family
ID=21346945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD940086A MD21B1 (en) | 1988-02-29 | 1994-02-25 | Method for obtaining 22 (r, s) 11beta, 21-dihydroxy-16alpha, 17-butylidenbisoxypregn-1,4-diene-3,20 dione |
Country Status (3)
| Country | Link |
|---|---|
| LT (1) | LT2202B (en) |
| LV (1) | LV5274A3 (en) |
| MD (1) | MD21B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD320Z (en) * | 2010-05-24 | 2011-08-31 | Государственный Университет Молд0 | Installation for the regeneration of cartridge with activated carbon or mineral sorbents used for purification of water from organic compounds |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3037914A (en) * | 1960-05-06 | 1962-06-05 | American Cyanamid Co | Bacterial production of triamcinolone by bacterial formulations |
| DE2323215A1 (en) * | 1972-05-19 | 1973-11-29 | Bofors Ab | STEROIDS, THE METHOD OF MANUFACTURING THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM |
-
1993
- 1993-01-18 LV LV930050A patent/LV5274A3/en unknown
- 1993-08-13 LT LTRP857A patent/LT2202B/en not_active IP Right Cessation
-
1994
- 1994-02-25 MD MD940086A patent/MD21B1/en not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3037914A (en) * | 1960-05-06 | 1962-06-05 | American Cyanamid Co | Bacterial production of triamcinolone by bacterial formulations |
| DE2323215A1 (en) * | 1972-05-19 | 1973-11-29 | Bofors Ab | STEROIDS, THE METHOD OF MANUFACTURING THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM |
Non-Patent Citations (4)
| Title |
|---|
| J.A.C.S., 1956, 78, 909. * |
| J.A.C.S., 1958, 80, 2338. * |
| J.A.C.S., 1959, 81, 1689. * |
| Thalen A. and R. Brattsand. Synthesls and Antilflmmatory Properties of Budesondle. A new: Non-halogenated Nucocorticold with High Local Activity-Arznel Forschung, 1979, 29(11), 1887. * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD320Z (en) * | 2010-05-24 | 2011-08-31 | Государственный Университет Молд0 | Installation for the regeneration of cartridge with activated carbon or mineral sorbents used for purification of water from organic compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| LT2202B (en) | 1993-10-15 |
| LV5274A3 (en) | 1993-10-10 |
| MD21B1 (en) | 1994-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6530990A (en) | Process for the manufacture of budesonide | |
| CA2083041A1 (en) | Labeled compounds for use in a diagnostic breath test | |
| ES8707516A1 (en) | PROCESS FOR THE PRODUCTION OF -i(GAMMA)-BUTYROLACTONE. | |
| CA2019830A1 (en) | Method of producing symmetrical difatty acid diamides | |
| MD21C2 (en) | The method of obtaining 22(R,S)-11b, 21-dihidroxi-16a, 17 butylidenbisoxipregn-1,4-dien-3,20 dion | |
| US4213902A (en) | Process for producing steroidal 7α-acylthio-4-en-3-ones | |
| US3313809A (en) | Steroido[21, 20-d]isoxazoles | |
| PL255391A1 (en) | Method of obtaining pregnane derivatives | |
| AU1028588A (en) | Novel crystalline cefadroxil and method for producing it | |
| US4102907A (en) | Desulfinylation process for preparing androsta-4,9(11)-diene-3,17-dione | |
| US4031080A (en) | 16-Alpha-methyl-17 alpha-bromo-1,4-pregnadiene-21-ol-3,20-dione-derivatives | |
| AU7108491A (en) | Improved process for synthesis of 5alpha-cholest-8(14)-en- 3beta-ol-15-one and other 15-oxygenated sterols | |
| EP0534800A3 (en) | Regioselective synthesis of 1,5-diaryl pyrazole anti-inflammatory agents | |
| IE860879L (en) | 16,17-acetalsubstituted androstane-17-beta-carboxylic acid¹esters | |
| DE3563433D1 (en) | Process for the production of acetic acid from synthesis gas | |
| IE890128L (en) | Method of producing 2-substituted oximino-3-oxobutyric¹acids. | |
| EP0264168A3 (en) | Process for producing 6-hydroxy-2-naphthones | |
| JPS6466137A (en) | Production of (+)-5s-isopropyl-8-methyl-6e,8-nonadien-2-one | |
| US4097477A (en) | Steroid compounds and processes thereof | |
| US3000883A (en) | Preparation of 17alpha-hydroxyprogesterone and intermediates | |
| CA2051397A1 (en) | Oxidative preparation of 3,5-secoandrost-5-one-3,17.beta.-dioic acid | |
| GB1050218A (en) | ||
| JPS6468389A (en) | Novel n-acetyl-beta-d-glucosamine derivative | |
| HUT49120A (en) | Process for producing 16-methoxy-16-methyl-prostaglandin el derivative and its intermediate | |
| Lancaster | Synthesis of Bisimides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 1M4A | Expiration of terms |